Financials
- Market Capitalization 1.8 B
- Employee 14 K
- Founded 2023
- CEO Paul R. N. Kirchgraber
- Website www.fortrea.com
- Headquarter North Carolina, United States
- FIGI BBG01GZF9VY6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.6
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2059 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.81 USD | -2.29% | -0.70% | +18.94% | -6.63% | 1.80 B USD | ||
| 2076 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.35 USD | -2.62% | -4.56% | +10.56% | -30.93% | 1.79 B USD | ||
| 2099 | INBX Inhibrx Biosciences, Inc. - Common Stock | 122.48 USD | -1.17% | +20.24% | +53.23% | +52.00% | 1.80 B USD | ||
| 2103 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.60 USD | -2.78% | +1.19% | -0.71% | +19.66% | 1.75 B USD |